Attrition in Randomized Controlled Trials for Pediatric Chronic Conditions

Objective To examine attrition variables in randomized controlled trials of cognitive behavioral interventions for children with chronic illnesses. Methods We examined attrition rates reported on 40 randomized cognitive behavioral interventions published in six pediatric research journals, during th...

Full description

Saved in:
Bibliographic Details
Published inJournal of pediatric psychology Vol. 34; no. 7; pp. 782 - 793
Main Authors Karlson, Cynthia W., Rapoff, Michael A.
Format Journal Article
LanguageEnglish
Published Atlanta, GA Oxford University Press 01.08.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To examine attrition variables in randomized controlled trials of cognitive behavioral interventions for children with chronic illnesses. Methods We examined attrition rates reported on 40 randomized cognitive behavioral interventions published in six pediatric research journals, during the years 2002–2007. Intervention focus was limited to children with a chronic medical condition, such as asthma, obesity, arthritis, diabetes, cancer, sickle cell disease, and cystic fibrosis. Results Mean rate of enrollment refusal was 37% (range 0–75%). Mean attrition rate was 20% (range 0–54%) for initial follow-up and 32% (range 0–59%) for extended follow-up. Of the reviewed articles, 40% included a CONSORT diagram. Conclusions Strategies that can be used to limit attrition include tailoring recruitment to the study population, providing personalized feedback, maintaining consistent study procedures, providing incentives, and using intensive tracking measures. There is a need for standardized definitions and reporting of attrition rates in randomized cognitive behavioral intervention studies.
Bibliography:ArticleID:jsn122
istex:6841AB07BBA5DF4663FD525ED40F52D5EAF6FACA
ark:/67375/HXZ-3L81WRHV-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0146-8693
1465-735X
1465-735X
DOI:10.1093/jpepsy/jsn122